Zacks Investment Research identified three promising dental supply company stocks, citing signs of market recovery amid the pandemic.
Three promising dental supply stocks, per Zacks:
McKesson Corp. (San Francisco): The healthcare services and information technology company's third-quarter fiscal 2021 performance exceeded original expectations. McKesson raised its fiscal 2021 guidance with adjusted earnings per share projected between $16.95 and $17.25 (up from the previously guided range of $16 to $16.50). The Zacks Consensus Estimate for 2021 revenues indicate an improvement of 3.8 percent.
West Pharmaceutical Services (Exton, Pa.): West Pharmaceutical manufactures and sells containment and delivery systems for injectable drugs and healthcare products both nationally and internationally. It delivered solid fourth-quarter 2020 performance and saw an advancement in pandemic-related sales. Solid revenue performance, especially in its biologics and generics market units and contract manufacturing, contributed to both bottom and top lines. The Zacks Consensus Estimate for 2021 revenues suggests growth of 18.7 percent.
Cardinal Health (Dublin, Ohio): Cardinal is a national drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company is the second largest pharmaceutical distributor in the U.S. The company remains focused on evolving growth areas with investments and partnerships in specialty, at-home and services. The Zacks Consensus Estimate for fiscal 2021 revenues suggests growth of 5.1 percent.
Click here for key trends shaping the future of the dental supply industry, per Zacks.